Trials / Not Yet Recruiting
Not Yet RecruitingNCT06900296
ImmuNe ParameTERs to Predict Immunotherapy REsponse and Toxicity (INTERPRET)
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Indiana University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective observational study that will collect blood samples at 1-10 timepoints related to initiation of immunotherapy. The study may collect samples before the start of immunotherapy and/or at clinically significant timepoints during immunotherapy treatment.
Detailed description
The long-term goal of this research is to identify immunologic and other blood-borne markers of immunotherapy efficacy and toxicity. The objective of this proposal is to identify associations between immunologic parameters and other blood-borne markers with treatment response, irAE development, or relevant biomarkers of both outcomes.
Conditions
Timeline
- Start date
- 2026-05-01
- Primary completion
- 2029-04-01
- Completion
- 2029-04-01
- First posted
- 2025-03-28
- Last updated
- 2025-10-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06900296. Inclusion in this directory is not an endorsement.